ClinicalTrials.govpublic full text
Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC
crc (colorectal cancer), mcrc, target therapy, 5mc/5hmc, 5-hydroxymethylation, metastatic colorectal cancer, anti-egfr therapy, anti-vegf therapy, ras/braf mutation, 5-methylcytosine, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 836824
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.